✦ LIBER ✦

P1-237: PET amyloid imaging with Pittsburgh compound B in Alzheimer's disease, mild cognitive impairment, and healthy controls

✍ Scribed by Davangere P. Devanand; Arthur Mikhno; Gregory H. Pelton; Katrina Cuasay; J.S. Dileep Kumar; Matthias H. Tabert; Gnanavalli Pradhaban; Neil Upton; Robert Lai; Vincenzo Libri; Roger N. Gunn; J. John Mann; Ramin V. Parsey

Book ID: 118464409
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 133 KB
Volume: 4
Category: Article
ISSN: 1552-5260
DOI: 10.1016/j.jalz.2008.05.826

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PET Amyloid imaging and cognition in pat

PET Amyloid imaging and cognition in patients with Alzheimer's disease, Mild Cognitive Impairment (MCI) and healthy controls: a European multicenter study

✍ Agneta Nordberg; Juha Rinne; Alexander Drzezga; David J. Brooks; Rik Vandenbergh 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 134 KB

Comparison of Pittsburgh compound B (11C

Comparison of Pittsburgh compound B (11C-PIB) and fluorodeoxyglucose (18F-FDG) PET in patients with Alzheimer's disease, mild cognitive impairment, and healthy controls

✍ Davangere P. Devanand; Arthur Mikhno; Gregory H. Pelton; Katrina Cuasay; J.S. Di 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 48 KB

Comparison of Pittsburgh compound B (11C

Comparison of Pittsburgh compound B (11C-PIB) and fluorodeoxyglucose (18F-FDG) PET in patients with Alzheimer's disease, Mild Cognitive Impairment and healthy controls

✍ Davangere P. Devanand; Arthur Mikhno; Gregory H. Pelton; Katrina Cuasay; J.S. Di 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 326 KB

O3-03-05 Human amyloid-imaging studies i

O3-03-05 Human amyloid-imaging studies in controls, mild cognitive impairment and Alzheimer's disease using Pittsburg compound-B

✍ William E. Klunk; Julie C. Price; Brian J. Lopresti; Manik L. Debnath; Daniel P. 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 147 KB

Appearance modeling of 11C PiB PET image

Appearance modeling of 11C PiB PET images: Characterizing amyloid deposition in Alzheimer's disease, mild cognitive impairment and healthy aging

✍ Jurgen Fripp; Pierrick Bourgeat; Oscar Acosta; Parnesh Raniga; Marc Modat; Kerry 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 909 KB

Amyloid PET in mild cognitive impairment

Amyloid PET in mild cognitive impairment and Alzheimer’s disease with BF-227: comparison to FDG–PET

✍ Katsutoshi Furukawa; Nobuyuki Okamura; Manabu Tashiro; Masaaki Waragai; Shozo Fu 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 448 KB